Celiac Disease Market Insights, Epidemiology and Market Forecast-2028


Albany, NY -- (SBWIRE) -- 07/25/2019 -- Celiac Disease Market Insights, Epidemiology and Market Forecast-2028

1. Celiac Disease is estimated to affect 1 in 100 people worldwide.
2. Celiac disease was found to be more common in women than in men and equally prevalent in children and adults.
3. An estimated 1 in 133 Americans have celiac disease. Celiac disease can affect men and women of all ages and races.

DelveInsight launched a new report on Celiac Disease Market Insights, Epidemiology and Market Forecast-2028

Key benefits

1. Celiac Disease market report covers a descriptive overview and comprehensive insight of the Celiac Disease epidemiology and Celiac Disease market in the 7 MM (United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.)
2. Celiac Disease market report provides insights on the current and emerging therapies.
3. Celiac Disease market report provides a global historical and forecasted market covering drug outreach in 7 MM.
4. Celiac Disease market report offers an edge that will help in developing business strategies by understanding trends shaping and driving the Celiac Disease market.
Request for sample pages

"5-22% of people with celiac disease have an immediate family member, who has celiac disease."

Currently, celiac disease treatment is lifelong adherence to a strict gluten-free diet. People living gluten-free must avoid foods with wheat, rye and barley, such as bread and beer. There are no celiac disease drugs. Owing to the lack of an approved celiac disease drug therapy, there remains a high unmet need for a therapy that can target the celiac disease and provide relief to the patients.
The increasing number of patients diagnosed with celiac disease as well as recent advances in characterization of its underlying pathology has driven the development of adjunctive or even alternative therapeutic approaches that could effectively manage or even cure this condition. Although several pharmacological agents for celiac disease are currently under development or has been tried in clinical studies, a gluten-free diet is still for celiac disease treatment option for these patients.
The dynamics of Celiac Disease market is anticipated to change in the coming years owing to the improvement in the diagnosis methodologies, raising awareness of the disease, incremental healthcare spending across the world and the expected launch of emerging therapies during the forecast period of 2019-2028. In order to meet the high unmet need of Celiac Disease treatment regimen, companies across the globe have shifted their focus toward this therapeutic area. The overall dynamics of Celiac Disease market is anticipated to change in the coming years owing to the expected launch of emerging therapies.

Expected launch of therapies such as
1. Larazotide or INN-202
3. Latiglutenase
4. Nexvax2
and many others

Key players like
1. Innovate Biopharmaceuticals
2. ImmunoGenX
3. Cour Pharmaceutical Development Company
4. ImmusanT
And many others

Table of contents

1. Key Insights
2. Celiac Disease Market Overview at a Glance
3. Celiac Disease Disease Background and Overview
4. Celiac Disease Epidemiology and Patient Population
5. Celiac Disease Total Prevalent Population in 7MM
6. United States Epidemiology
7. EU5 Epidemiology
7.1. Germany Epidemiology
7.2. France Epidemiology
7.3. Italy Epidemiology
7.4. Spain Epidemiology
7.5. United Kingdom Epidemiology
8. Japan Epidemiology
9. Celiac Disease Treatment Algorithm, Current Treatment, and Medical Practices
10. Unmet Needs
11. Celiac Disease Emerging Therapies
11.1.Key Cross Competition
11.2. Latiglutenase: Immunogenx
11.3. Larazotide: Innovate Biopharmaceuticals
11.4.TIMP-GLIA: Cour Pharmaceutical Development Company
11.5.Nexvax2: ImmusanT, Inc.
12. Celiac Disease Market Size
12.1.Key Findings
12.2.Total 7MM Celiac Disease Market Analysis
12.3. 7MM Country-Wise Market Analysis
12.4. United States: Market Outlook
12.4.1. United States Market Size
12.4.2. Germany Market Size
12.4.3. France Market Size
12.4.4. Italy Market Size
12.4.5. Spain Market Size
12.4.6. United Kingdom Market Size
13. Japan Market Outlook
13.1.Japan Market Size
14. Market Drivers
15. Market Barriers
16. Appendix
17. DelveInsight Capabilities
18. Disclaimer
19. About DelveInsight

About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end to end comprehensive solutions to improve their performance.

Contact us:
Shruti Thakur
SOURCE DelveInsight